{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:57:30Z","timestamp":1765742250510,"version":"3.48.0"},"reference-count":41,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["NIHR202744"],"award-info":[{"award-number":["NIHR202744"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,8,16]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Just under half of patients with obstructive sleep apnoea (OSA) also have gastro-oesophageal reflux disease (GORD). These conditions appear to be inter-related and continual positive airway pressure (CPAP) therapy, the gold standard treatment for OSA to prevent airway collapse, has been shown to reduce GORD. As the impact of mandibular advancement devices, a second-line therapy for OSA, on GORD has yet to be investigated, a feasibility study is needed prior to a definitive trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This will be a single-centre, single-blinded, tertiary-care based, interdisciplinary, parallel randomised controlled study. Potential OSA participants presenting to the sleep department will be pre-screened for GORD using validated questionnaires, consented and invited to receive simultaneous home sleep and oesophageal pH monitoring. Those with confirmed OSA and GORD (n=44) will be randomly allocated to receive either CPAP (n=22) or MAD therapy (n=22). Following successful titration and 3 weeks customisation period, participants will repeat the simultaneous sleep and oesophageal pH monitoring while wearing the device. The number of patients screened for recruitment, drop-out rates, patient feedback of the study protocol, costs of interventions and clinical information to inform a definitive study design will be investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      Health Research Authority approval has been obtained from the Nottingham 2 Research Ethics Committee, ref:22\/EM\/0157 and the trial has been registered on ISRCTN (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1186\/ISRCTN16013232\">https:\/\/doi.org\/10.1186\/ISRCTN16013232<\/jats:ext-link>\n                      ). Definitive findings about the feasibility of doing 24\u2009hour pH oesophageal monitoring while doing a home sleep study will be disseminated via clinical and research networks facilitating valuable insights into the simultaneous management of both conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ISRCTN Reg No: 16013232.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-076661","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T22:28:27Z","timestamp":1692916107000},"page":"e076661","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial)"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2144-1847","authenticated-orcid":false,"given":"Saoirse","family":"O'Toole","sequence":"first","affiliation":[{"name":"Centre for Clinical, Oral and Translational Sciences, King's College London, London, UK"},{"name":"School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Moazzez","sequence":"additional","affiliation":[{"name":"Restorative Dentistry, University of the Pacific Arthur A Dugoni School of Dentistry, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4635-4800","authenticated-orcid":false,"given":"Gabriella","family":"Wojewodka","sequence":"additional","affiliation":[{"name":"Oral and Clinical Research Unit, King's College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Zeki","sequence":"additional","affiliation":[{"name":"Oesophageal Physiology Laboratory, Guy's and St Thomas' Hospitals NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Jafari","sequence":"additional","affiliation":[{"name":"Oesophageal Physiology Laboratory, Guy's and St Thomas' Hospitals NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hope","sequence":"additional","affiliation":[{"name":"Hope2Sleep, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Brand","sequence":"additional","affiliation":[{"name":"NWORTH (North Wales Organisation for Randomised Trials in Health), School of Medical and Health Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-5482","authenticated-orcid":false,"given":"Zoe","family":"Hoare","sequence":"additional","affiliation":[{"name":"NWORTH (North Wales Organisation for Randomised Trials in Health), School of Medical and Health Sciences, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Scott","sequence":"additional","affiliation":[{"name":"Queen Mary University of London Wolfson Institute of Population Health, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodchawan","family":"Doungsong","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victory","family":"Ezeofor","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4748-5730","authenticated-orcid":false,"given":"Rhiannon Tudor","family":"Edwards","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagis","family":"Drakatos","sequence":"additional","affiliation":[{"name":"Oesophageal Physiology Laboratory, Guy's and St Thomas' Hospitals NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1587-3109","authenticated-orcid":false,"given":"Joerg","family":"Steier","sequence":"additional","affiliation":[{"name":"Lane Fox Unit\/Sleep Disorders Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK"},{"name":"School of Medicine, King's College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"2025121411534842000_13.8.e076661.1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S2213-2600(19)30402-3","article-title":"Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised controlled trial","volume":"8","author":"Wimms","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025121411534842000_13.8.e076661.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(01)00072-7"},{"key":"2025121411534842000_13.8.e076661.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013983","article-title":"Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis","volume":"7","author":"Xie","year":"2017","journal-title":"BMJ Open"},{"key":"2025121411534842000_13.8.e076661.4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5665\/sleep.4486","article-title":"Sleep apnea related risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish traffic accident registry data","volume":"38","author":"Karimi","year":"2015","journal-title":"Sleep"},{"key":"2025121411534842000_13.8.e076661.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166262","article-title":"Sleep apnea, sleep debt and daytime sleepiness are independently associated with road accidents. a cross-sectional study on truck drivers","volume":"11","author":"Garbarino","year":"2016","journal-title":"PLoS One"},{"key":"2025121411534842000_13.8.e076661.6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13643-021-01651-3","article-title":"Economic evaluation of diagnostic sleep studies for obstructive sleep apnoea: a systematic review protocol","volume":"10","author":"Natsky","year":"2021","journal-title":"Syst Rev"},{"key":"2025121411534842000_13.8.e076661.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268677","article-title":"The invisible costs of obstructive sleep apnea (OSA): systematic review and cost-of-illness analysis","volume":"17","author":"Borsoi","year":"2022","journal-title":"PLoS One"},{"key":"2025121411534842000_13.8.e076661.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"2025121411534842000_13.8.e076661.9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjoto.2018.09.006","article-title":"Laryngopharyngeal reflux in obstructive sleep apnoea patients: literature review and meta-analysis","volume":"39","author":"Magliulo","year":"2018","journal-title":"Am J Otolaryngol"},{"key":"2025121411534842000_13.8.e076661.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04124.x"},{"key":"2025121411534842000_13.8.e076661.11","unstructured":"NICE . Obstructive sleep apnoea\/ hypopnoea syndrome and obesity hypoventilation syndrome in over 16S NICE guideline, NICE guideline [Ng202]; 2021. Available: www.nice.org.uk\/guidance\/ng202"},{"key":"2025121411534842000_13.8.e076661.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.4.1003"},{"key":"2025121411534842000_13.8.e076661.13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.14309\/ajg.0000000000000627","article-title":"Temporal relationship between night-time gastroesophageal reflux events and arousals from sleep","volume":"115","author":"Shepherd","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2025121411534842000_13.8.e076661.14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.1.41"},{"key":"2025121411534842000_13.8.e076661.15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.5664\/jcsm.6126","article-title":"Effect of CPAP therapy on symptoms of nocturnal gastroesophageal reflux among patients with obstructive sleep apnea","volume":"12","author":"Tamanna","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"2025121411534842000_13.8.e076661.16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11325-010-0404-x","article-title":"Mechanisms of nocturnal gastroesophageal reflux events in obstructive sleep apnea","volume":"15","author":"Shepherd","year":"2011","journal-title":"Sleep Breath"},{"key":"2025121411534842000_13.8.e076661.17","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-017-1590-6"},{"key":"2025121411534842000_13.8.e076661.18","doi-asserted-by":"publisher","DOI":"10.3310\/hta18520"},{"key":"2025121411534842000_13.8.e076661.19","unstructured":"Rej\u00f3n-Parrilla JC , Garau M , Sussex J . Obstructive sleep apnoea health economics report consulting report for the British lung foundation; 2014."},{"key":"2025121411534842000_13.8.e076661.20","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.086454"},{"key":"2025121411534842000_13.8.e076661.21","doi-asserted-by":"crossref","unstructured":"Grant A . Health technology assessment NIHR HTA programme www.hta.ac.uk the effectiveness and cost-effectiveness of minimal access surgery amongst people with Gastro-Oesophageal reflux disease-a UK collaborative study. the reflux trial. 2008. Available: www.hta.ac.uk","DOI":"10.3310\/hta12310"},{"key":"2025121411534842000_13.8.e076661.22","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2025121411534842000_13.8.e076661.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.08.023"},{"key":"2025121411534842000_13.8.e076661.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9927-2"},{"key":"2025121411534842000_13.8.e076661.25","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-5-63","article-title":"The Warwick-Edinburgh mental well-being scale (WEMWBS): development and UK validation","volume":"5","author":"Tennant","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"2025121411534842000_13.8.e076661.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0892-1997(02)00097-8"},{"key":"2025121411534842000_13.8.e076661.27","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/14.6.540"},{"key":"2025121411534842000_13.8.e076661.28","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.339"},{"key":"2025121411534842000_13.8.e076661.29","doi-asserted-by":"crossref","unstructured":"Sekhon M , Cartwright M , Francis JJ . Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017;17. doi:10.1186\/s12913-017-2031-8","DOI":"10.1186\/s12913-017-2031-8"},{"key":"2025121411534842000_13.8.e076661.30","unstructured":"Bryman A , Burgess RG . Qualitative data analysis for applied policy research. London: Routledge, 1994."},{"key":"2025121411534842000_13.8.e076661.31","doi-asserted-by":"crossref","unstructured":"Gannon B . The feasibility study: a health economics perspective. Glob Reg Health Technol Assess 2017;4. doi:10.5301\/grhta.5000254","DOI":"10.5301\/grhta.5000254"},{"key":"2025121411534842000_13.8.e076661.32","doi-asserted-by":"crossref","unstructured":"Tudor Edwards R , McIntosh E . Applied health economics for public health practice and research. Oxford University Press, 2019.","DOI":"10.1093\/med\/9780198737483.001.0001"},{"key":"2025121411534842000_13.8.e076661.33","unstructured":"Drummond MF , Sculpher MJ , Claxton K , et al . Methods for the economic evaluation of health care programmes, 4th ed. Oxford University Press, 2015."},{"key":"2025121411534842000_13.8.e076661.34","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n2061","article-title":"A new framework for developing and evaluating complex interventions: update of medical research council guidance","volume":"374","author":"Skivington","year":"2021","journal-title":"BMJ"},{"key":"2025121411534842000_13.8.e076661.35","doi-asserted-by":"crossref","unstructured":"Cookson R , Griffin S , Norheim OF , et al . Distributional cost-effectiveness analysis: quantifying health equity impacts and trade-offs costs and health effects. Oxford University Press, 2020.","DOI":"10.1093\/med\/9780198838197.001.0001"},{"key":"2025121411534842000_13.8.e076661.36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067975","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"376","author":"Husereau","year":"2022","journal-title":"BMJ"},{"key":"2025121411534842000_13.8.e076661.37","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0327-2"},{"key":"2025121411534842000_13.8.e076661.38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2025121411534842000_13.8.e076661.39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.6.1539"},{"key":"2025121411534842000_13.8.e076661.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.09.002"},{"key":"2025121411534842000_13.8.e076661.41","doi-asserted-by":"publisher","DOI":"10.1111\/j..2002.384.doc.x"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-076661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:53:57Z","timestamp":1765742037000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-076661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,24]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/bmjopen-2023-076661"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-076661","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}